Information Library
News Items - Flexible outsourcing
To learn more about a particular aspect of Quintiles’ pharma services, biotech development or drug commercialization services, select a topic at left. If you’ve already specified a choice, you may narrow your search by selecting additional categories in any order. For example, for information on oncology drug development, start by selecting oncology. Then you can narrow your search to Central Lab, News Releases and Europe.
- Sort by:
- Most Recent
- Title
-
QUINTILES AND MOVETIS ANNOUNCE STRATEGIC ALLIANCE
January 28, 2010 - Quintiles announced a strategic alliance with Movetis NV for commercialization of its new product, Resolor (prucalopride), in the U.K. and Germany.
-
QUINTILES HONORED AS CRO OF THE YEAR AT 2009 SCRIP AWARD
Research Triangle Park, NC, December 14, 2009 – Quintiles has been named CRO of the Year by the prestigious SCRIP Awards. The panel of judges highlighted Quintiles’ breadth of services and its outstanding relationships with clients.
-
INNOVEX AND HEALTHCARE AT HOME ANNOUNCE JOINT VENTURE
September 29, 2009 - Innovex, a Quintiles company, and Healthcare at Home today announced that they have agreed to form an innovative healthcare joint venture in Europe, named Healthcare at Home Europe.
-
QUINTILES AND ALLERGAN ANNOUNCE CO-PROMOTION AGREEMENT
September 25, 2009 – Quintiles Transnational Corp. and Allergan, Inc. today announced an agreement under which Quintiles will co-promote Allergan's SANCTURA XR®.
-
QUINTILES WINS PFIZER DEVELOPMENT OPERATIONS STRATEGIC SUPPLIER EXCELLENCE AWARD
JUNE 10, 2009 – Quintiles announces that its Data Management division has received the 2008 Pfizer Development Operations’ Strategic Supplier Excellence Award.
Page 1 of 1 (5 results)
